Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Share Price    (AJPH)

Here is the latest stock price and chart of AJANTA PHARMA. For more details, see the AJANTA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

SHOCKING: Ex-Swiss Investment Banker's Lucrative Income Generating Secret

REFRESH
Live BSE Quotes Dec 4, 2020 10:58:00 AM
Price (Rs)1,570.00 Open (Rs) 1,566.50 High (Rs) 1,574.25 Low (Rs) 1,562.00
% Change0.81 Volume 1,194 Value (Rs) 1,874,580 52-Week H/L 1,759.35 / 943.00
Live NSE Quotes Dec 4, 2020 10:59:58 AM
Price (Rs)1,571.70 Open (Rs) 1,561.00 High (Rs) 1,574.00 Low (Rs) 1,561.00
% Change0.89 Volume 34,805 Value (Rs) 54,547,788 52-Week H/L 1,759.95 / 942.25
Change
1 Day
0.81%
1 Month
-2.64%
3 Months
5.23%
1 Year
60.16%
5 Years (CAGR)*
3.26%
10 Years (CAGR)*
49.25%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 63.07 P/E Ratio (x) 24.89 Market Cap (Rs m) 138,081.50 P/BV (x) 6.15
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

AJANTA PHARMA Share Price Today:

AJANTA PHARMA share price is up 0.8% to Rs 1,570.0 on the BSE. On the NSE, the AJANTA PHARMA share price is up 0.9% to Rs 1,571.7. The total volume of shares traded is 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.1%. And the benchmark S&P BSE SENSEX is at 44,995.5 (up 0.8%).

Over the last 30 days, the AJANTA PHARMA share price is down 0.3%. And over the last one year, AJANTA PHARMA share price is up 58.5%.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Opens Higher Ahead of RBI Policy Decision; SpiceJet Zooms 10%(09:30 am)

Asian share markets are trading lower today as US legislators wrangled over a fiscal stimulus and negotiations over a Brexit trade deal continued.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS